[1]汪 艳,杨 俊,段会仙,等.糖耐量异常患者血清癌胚抗原相关细胞黏附分子1与 动脉粥样硬化的关系[J].医学信息,2019,(18):55-58.[doi:10.3969/j.issn.1006-1959.2019.18.018]
 WANG Yan,YANG Jun,DUAN Hui-xian,et al.Relationship between Serum Carcinoembryonic Antigen-associated Cell Adhesion Molecule-1 and Atherosclerosis in Patients with Impaired Glucose Tolerance[J].Medical Information,2019,(18):55-58.[doi:10.3969/j.issn.1006-1959.2019.18.018]
点击复制

糖耐量异常患者血清癌胚抗原相关细胞黏附分子1与 动脉粥样硬化的关系 ()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2019年18期
页码:
55-58
栏目:
论著
出版日期:
2019-09-15

文章信息/Info

Title:
Relationship between Serum Carcinoembryonic Antigen-associated Cell Adhesion Molecule-1 and Atherosclerosis in Patients with Impaired Glucose Tolerance
文章编号:
1006-1959(2019)18-0055-04
作者:
汪 艳1杨 俊1段会仙1赵仲文1苗文清1王 宇1于 杰2
1.昆明市第一人民医院心血管内科,云南 昆明 650011; 2.解放军联勤保障部队第九二〇医院心胸外科,云南 昆明 650032
Author(s):
WANG Yan1YANG Jun1DUAN Hui-xian1ZHAO Zhong-wen1MIAO Wen-qing1WANG Yu1YU Jie2
1.Department of Cardiology,Kunming First People's Hospital,Kunming 650011,Yunnan,China; (2.Department of Cardiothoracic Surgery,920 Hospital of the Joint Service Support Force of the People's Liberation Army, Kunming 650032,Yunnan,China
关键词:
糖耐量异常癌胚抗原相关细胞粘附分子1颈动脉粥样硬化
Keywords:
Key words:Abnormal glucose toleranceCarcinoembryonic antigen-associated cell adhesion molecule 1Carotid atherosclerosis
分类号:
R730.2
DOI:
10.3969/j.issn.1006-1959.2019.18.018
文献标志码:
A
摘要:
目的 探讨血清癌胚抗原相关细胞粘附分子1(CEACAM1)与糖耐量异常(IGT)患者合并颈动脉粥样硬化(CAS)的相关性。方法 选取2015年10月~2017年10月我院收治的IGT患者80例,根据颈动脉彩色多普勒超声结果分为IGT组44例和IGT+CAS组36例,另选取同期我院健康体检者30名作为正常对照组(NGT组),比较三组临床指标(TG、TC、LDL-C等),分析血清CEACAM1与临床指标的相关性及其影响因素。结果 三组年龄、性别、BMI、SBP、DBP比较,差异无统计学意义(P>0.05)。IGT组和IGT+CAS组TG、TC、LDL-C、FBG、HbA1c、FINS、HOMA-IR、hs-CRP、IL-6、TNF-α均高于NGT组,HDL-C低于NGT组,差异有统计学意义(P<0.05);IGT+CAS组TG、TC、LDL-C、FBG、FINS、HOMA-IR、IL-6、TNF-α高于IGT组,HbA1c、HDL-C低于IGT组,差异有统计学意义(P<0.05)。IGT+CAS组、IGT组CEACAM1水平低于NGT组,IGT+CAS组CEACAM1水平低于IGT组,IGT组CEACAM1水平低于NGT组,差异有统计学意义(P<0.05)。Pearson相关性分析表明,IGT患者血清CEACAM1与TC、LDL-C、FBG、HbA1c、FINS、HOMA-IR呈负相关,与HDL-C呈正相关(P<0.05);与年龄、BMI、SBP、DBP、TG、hs-CRP、IL-6、TNF-α无相关性(P>0.05)。多元线性回归结果显示,TC、HDL-C和HbA1c是血清CEACAM1的独立影响因素。结论 CEACAM1可能与IGT的发生发展有关;CEACAM1水平降低,可能是IGT患者CAS发生发展的原因之一。
Abstract:
Abstract:Objective To investigate the correlation between serum carcinoembryonic antigen-associated cell adhesion molecule 1 (CEACAM1) and carotid atherosclerosis (CAS) in patients with impaired glucose tolerance (IGT). Methods 80 patients with IGT admitted to our hospital from October 2015 to October 2017 were enrolled. According to the results of carotid color Doppler ultrasound, 44 patients in the IGT group and 36 patients in the IGT+CAS group were selected. Thirty patients were used as normal control group (NGT group), and three groups of clinical indicators (TG, TC, LDL-C, etc.) were compared. The correlation between serum CEACAM1 and clinical indicators and its influencing factors were analyzed. Results There were no significant differences in age, gender, BMI, SBP and DBP between the three groups (P>0.05). TG, TC, LDL-C, FBG, HbA1c, FINS, HOMA-IR, hs-CRP, IL-6, TNF-α in IGT group and IGT+CAS group were higher than NGT group, and HDL-C was lower than NGT group,the difference was statistically significant (P<0.05);TG, TC, LDL-C, FBG, FINS, HOMA-IR, IL-6, TNF-α in IGT+CAS group were higher than IGT group, HbA1c and HDL-C were lower than IGT group, the difference was statistically significant (P<0.05). The levels of CEACAM1 in IGT+CAS group and IGT group were lower than those in NGT group. The level of CEACAM1 in IGT+CAS group was lower than that in IGT group. The level of CEACAM1 in IGT group was lower than that in NGT group,the difference was statistically significant (P<0.05). Pearson correlation analysis showed that serum CEACAM1 was negatively correlated with TC, LDL-C, FBG, HbA1c, FINS and HOMA-IR in IGT patients (P<0.05), and positively correlated with HDL-C (P<0.05). There was no correlation between age,BMI, SBP, DBP, TG, hs-CRP, IL-6 and TNF-α (P>0.05). Multiple linear regression results showed that TC, HDL-C and HbA1c were independent factors influencing serum CEACAM1.Conclusion CEACAM1 may be involved in the development of IGT. The decrease of CEACAM1 may be one of the reasons for the development of CAS in patients with IGT.

参考文献/References:

[1]Enzo B,Stefan K,Johann W,et al.Prevalence of insulin resistance in metabolic disorders:the Bruneck Study[J].Diabetes,1998,47(10):1643-1649. [2]Amini M,Janghorbani M.Diabetes and impaired glucose regulation in first-degree relatives of patients with type 2 diabetes in isfahan,iran:prevalence and risk factors[J].Rev Diabet Stud,2007,4(3):169-176. [3]裴晓艳,金国玺,毕娅欣,等.血清骨钙素、白细胞介素-18在不同糖耐量人群的变化及其与2型糖尿病颈动脉粥样硬化的关系[J].中国循环杂志,2017,32(7):684-688. [4]余显霞,曹蕾,熊雪松.阿司匹林肠溶片联合阿托伐他汀钙片对糖尿病动脉粥样硬化的干预治疗研究[J].川北医学院学报,2017,32(3):358-360. [5]吴利,朱红,曹长春,等.2型糖尿病患者颈动脉及下肢动脉硬化相关危险因素分析[J].当代医学,2018,24(6):12-15. [6]Heinrich G,Ghadieh HE,Ghanem SS,et al.Loss of Hepatic CEACAM1:A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease[J].Front Endocrinol (Lausanne),2017(8):8. [7]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-67. [8]中国健康体检人群颈动脉超声检查规范[J].中华健康管理学杂志,2015,(4):254-260. [9]Xu Y,Wang L,He J,et al.Prevalence and control of diabetes in Chinese adults[J].JAMA,2013,310(9):948-959. [10]Friedrich SK,Lang PA,Friebus-Kardash J,et al.Mechanisms of lymphatic system-specific viral replication and its potential role in autoimmune disease[J].Clinical and Experimental Immunology,2019,195(1):64-73. [11]Nagaishi T,Iijima H,Nakajima A,et al. Role of CEACAM1 as a regulator of T cells[J].Ann N Y Acad Sci,2006(1072):155-175. [12]Weiner GM,Ducruet AF.CEACAM1:a novel adhesion molecule that regulates the secretion of matrix metalloproteinase-9 in neutrophils and protects the blood-brain barrier after ischemic stroke[J].Neurosurgery,2014,75(4):N21-N22. [13]Wang Y,Chen Y,Yan Y,et al.Loss of ceacam1,a tumor-associated factor,attenuates post-infarction cardiac remodeling by inhibiting apoptosis[J].Scientific Reports,2016(6):21972. [14]DeAngelis AM,Heinrich G,Dai T,et al.Carcinoembryonic antigen-related cell adhesion molecule 1:A link between insulin and lipid metabolism[J].Diabetes,2008,57(9):2296-2303. [15]张凤丽,何立娟,崔清华,等.血清胎球蛋白A水平对糖耐量减低的预测价值[J].疑难病杂志,2018,17(5):464-467.

更新日期/Last Update: 2019-09-15